Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07582237

Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Dermatitis, Atopic Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bucheon Hospital, Soonchunhyang University

Bucheon-si, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those who participated in the K0106 clinical trial and received FURESTEM-AD Inj
  • Those who understand and voluntarily sign an informed consent form

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Safety Assessment

    Time frame: 5 years follow-up after treatment

    Rate and Number of AESI(Adverse Event of Special Interest) and SS(Special Situation)

Secondary outcomes

  1. EASI(Eczema Area and Severity Index) Score

    Time frame: 1 year, 2 years, 3 years after treatment

  2. IGA(Investigator's Global Assessment) Score

    Time frame: 1 year, 2 years, 3 years after treatment

  3. Pruritus NRS(Numerical Rating Scale) Score

    Time frame: 1 year, 2 years, 3 years after treatment

Sponsors and collaborators

Lead sponsor

Kang Stem Biotech Co., Ltd.

Industry

Registry information

Official study title

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Important dates

Study start
2021
Primary completion
2028
Study completion
2029
First posted
May 12, 2026
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.